ONCOLOGY

Upcoming Events

9th Annual Puerto Rico Winter Cancer Symposium

La Concha Hotel
San Juan, Puerto Rico

 

This three-day conference is designed for medical oncologists, radiation oncologists, surgical oncologists, advances registered nurse practitioners (ARNP), physician assistants (PA), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of a review of the standard of care and new developments in cancer therapy. Residents in training and fellows from these specialties are encouraged to attend. Topics in breast cancer, gastrointestinal (GI) malignancies, head and neck cancers, hematological malignancies (i.e., multiple myeloma, CLL, CML, and Non-Hodgkin’s lymphoma) genito-urinary cancers (GU), brain tumors, malignant melanoma, and non-small cell lung cancer (NSCLC) will be presented.

 

The areas of focus for this conference will include the review of current standards of care in the treatment of all malignancies and new developments in cancer care. There will be an emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. Presentations from latest national and international meetings will be reviewed and guidelines of cancer care will be emphasized.

 

For complete conference details, to register and book your hotel, visit: 2020 WCS

17th Annual Miami Cancer Meeting

Trump National Doral
Miami, Florida

 

This three-day conference is designed for medical oncologists, radiation oncologists, surgical oncologists, advances registered nurse practitioners (ARNP), physician assistants (PA), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of a review of the standard of care and new developments in cancer therapy. Residents in training and fellows from these specialties are encouraged to attend.

 

Topics in breast cancer, gastrointestinal (GI) malignancies, head and neck cancers, hematological malignancies (i.e., multiple myeloma, CLL, CML, and Non-Hodgkin’s lymphoma) genito-urinary cancers (GU), brain tumors, malignant melanoma, and non-small cell lung cancer (NSCLC) will be presented. The areas of focus for this conference will include the review of current standards of care in the treatment of all malignancies and new developments in cancer care. There will be an emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. Presentations from latest national and international meetings will be reviewed and guidelines of cancer care will be emphasized.

 
For conference details, to register to the event and make your hotel reservation, visit 2020 MCM

15th Annual New Orleans Summer Cancer Meeting (NOSCM)

The Roosevelt New Orleans Hotel

New Orleans, LA

 

The 15th Annual New Orleans Summer Cancer Meeting (NOSCM) is a major CME/CE event well established in the Southeast region of the United States. In 2020, the meeting has innovations: simultaneous sessions running in parallel, one for physicians and the other one for nurses. Also, a special emphasis has been dedicated to immunotherapy as more clinical indications are coming up as well as different therapeutic compounds with different companion diagnostic tests which require a careful review on the clinical data. Moreover, based on evaluations from the previous 14 consecutive years, this meeting will provide healthcare professionals taking care of cancer patients with the necessary tools to offer the best quality of care to their patients. The 15th edition of this national CME/CE program will focus on integrating major advances in basic sciences and how to apply them into the routine clinical practice, and hence, deliver customized therapy to each individual patient. In 2020, the Educational Committee decided to continue with topics such as brain tumor, sarcoma, gynecologic malignancies, and geriatric oncology and best supportive of care. As we know, all progress in oncology will not be possible if we do not have the support from novel technology in radiation therapy as well as new diagnostic tools such as liquid biopsy. In the 15th Annual NOSCM, discussion on these techniques will take place. The hematology session in 2020 will have the participation of renowned hematologists who will cover the major hematologic malignancies including lymphoma, myeloma and leukemias.

 

For complete conference information, to register and reserve your hotel room, visit: NOSCM 2020

16th Annual California Cancer Consortium Conference (CCC)

The Langham Hotel

Pasadena, CA

 

Conference information, registration and hotel reservation information coming soon.

16th Annual New Orleans Summer Cancer Meeting (NOSCM)

The Roosevelt New Orleans Hotel

New Orleans, LA

 

Conference information, registration and hotel reservation information coming soon.

20th Annual Advances in Oncology

Kimpton Sawyer Hotal
Sacramento, California

 

The 20th Annual Advances in Oncology program will bring together academic and community oncologists for the purpose of educating participants on the state-of-heart clinical management of a wide variety of solid and hematologic malignancies. The program is designed to update physicians and other cancer healthcare providers on recent advances and new diagnostic and treatment modalities in hematologic, breast, lung, gastrointestinal, and genitourinary cancers.

 

For conference information, to register and book your hotel today visit: 20th Advances in Oncology Conference

5th Annual Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting

Hilton Hawaiian Village Waikiki Beach Resort
Honolulu, Hawaii

 

The 5th Annual Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting is designed to summarize key developments in cancer care over the past 12 months and features anticipated advances that HCPs will likely see in the upcoming year.

 

Secure your spot and join our distinguished faculty at the PRIMO meeting in Honolulu, Hawaii on February 12-15, 2020 and participate in the discussion regarding:

  • Practical considerations of applying biomarkers and targeted therapy
  • Integration of immunotherapy, with a focus on novel management approaches
  • Patient selection, as well as timing and sequencing of therapy
  • Dealing with important trends, such as big data and defining value in cancer care

 

For conference details, to register to the event and make your hotel reservation, visit www.primomeeting.org

Master Lecture Series: Evolving Treatments in Immunotherapy & Targeted Therapies

The Roosevelt Hotel
New Orleans, Louisiana

 

This Master Lecture Series will provide current, practical information on the management of immunotherapy and target therapies. We will discuss the novel agents and strategies with the potential to shape the future of cancer therapy. Leading experts will address critical topics in personalized therapy, and the latest clinical data impacting the treatment of GI, GU (PAR Inhibitors), melanoma, lung (RET/MET/ VEGFR2 & breast cancer (HER2 PI3K/Akt). Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

 

For conference details, to register to the event and make your hotel reservation, visit 2020 MLS New Orleans

Master Lecture Series: Evolving Treatments in Immunotherapy & Targeted Therapies

Hilton Union Square Hotel
San Francisco, California

 

This Master Lecture Series will provide current, practical information on the management of immunotherapy and target therapies. We will discuss the novel agents and strategies with the potential to shape the future of cancer therapy. Leading experts will address critical topics in personalized therapy, and the latest clinical data impacting the treatment of GI, GU (PAR Inhibitors), melanoma, lung (RET/MET/ VEGFR2 & breast cancer (HER2 PI3K/Akt). Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

 

For conference details, to register to the event and make your hotel reservation, visit 2020 MLS San Francisco